Live-type Poultry Vaccine Market Report – Research, Industry Analysis Reports and Market Demands

Global Live-type Poultry Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Live-type Poultry Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Newcastle Disease Vaccine
- 1.3.3 Infectious Bronchitis Vaccine
- 1.3.4 Fowl Pox Vaccine
- 1.3.5 Marek’s Disease Vaccine
- 1.3.6 Fowl Typhoid Vaccine
- 1.3.7 Live Coccidiosis Vaccine
- 1.3.8 Other
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Live-type Poultry Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Chicken
- 1.4.3 Other Poultry
1.5 Global Live-type Poultry Vaccine Market Size & Forecast
- 1.5.1 Global Live-type Poultry Vaccine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Live-type Poultry Vaccine Sales Quantity (2020-2031)
- 1.5.3 Global Live-type Poultry Vaccine Average Price (2020-2031)

2 Manufacturers Profiles

3 Competitive Environment: Live-type Poultry Vaccine by Manufacturer

3.1 Global Live-type Poultry Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Live-type Poultry Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Live-type Poultry Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Live-type Poultry Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Live-type Poultry Vaccine Manufacturer Market Share in 2024
- 3.4.3 Top 6 Live-type Poultry Vaccine Manufacturer Market Share in 2024
3.5 Live-type Poultry Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Live-type Poultry Vaccine Market: Region Footprint
- 3.5.2 Live-type Poultry Vaccine Market: Company Product Type Footprint
- 3.5.3 Live-type Poultry Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Live-type Poultry Vaccine Market Size by Region
- 4.1.1 Global Live-type Poultry Vaccine Sales Quantity by Region (2020-2031)
- 4.1.2 Global Live-type Poultry Vaccine Consumption Value by Region (2020-2031)
- 4.1.3 Global Live-type Poultry Vaccine Average Price by Region (2020-2031)
4.2 North America Live-type Poultry Vaccine Consumption Value (2020-2031)
4.3 Europe Live-type Poultry Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Live-type Poultry Vaccine Consumption Value (2020-2031)
4.5 South America Live-type Poultry Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Live-type Poultry Vaccine Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Live-type Poultry Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Live-type Poultry Vaccine Consumption Value by Type (2020-2031)
5.3 Global Live-type Poultry Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Live-type Poultry Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Live-type Poultry Vaccine Consumption Value by Application (2020-2031)
6.3 Global Live-type Poultry Vaccine Average Price by Application (2020-2031)

7 North America

7.1 North America Live-type Poultry Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Live-type Poultry Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Live-type Poultry Vaccine Market Size by Country
- 7.3.1 North America Live-type Poultry Vaccine Sales Quantity by Country (2020-2031)
- 7.3.2 North America Live-type Poultry Vaccine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Live-type Poultry Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Live-type Poultry Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Live-type Poultry Vaccine Market Size by Country
- 8.3.1 Europe Live-type Poultry Vaccine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Live-type Poultry Vaccine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Live-type Poultry Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Live-type Poultry Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Live-type Poultry Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Live-type Poultry Vaccine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Live-type Poultry Vaccine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Live-type Poultry Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Live-type Poultry Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Live-type Poultry Vaccine Market Size by Country
- 10.3.1 South America Live-type Poultry Vaccine Sales Quantity by Country (2020-2031)
- 10.3.2 South America Live-type Poultry Vaccine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Live-type Poultry Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Live-type Poultry Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Live-type Poultry Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Live-type Poultry Vaccine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Live-type Poultry Vaccine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Live-type Poultry Vaccine Market Drivers
12.2 Live-type Poultry Vaccine Market Restraints
12.3 Live-type Poultry Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Live-type Poultry Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live-type Poultry Vaccine
13.3 Live-type Poultry Vaccine Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Live-type Poultry Vaccine Typical Distributors
14.3 Live-type Poultry Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Live-type Poultry Vaccine market size was valued at US$ 994 million in 2024 and is forecast to a readjusted size of USD 1322 million by 2031 with a CAGR of 4.2% during review period.
A live-type poultry vaccine contains a virus or bacteria that must infect the chicken and multiply in its body to produce immunity, preferably with minimal reaction. Multiplication of the virus in the chicken is necessary, as only relatively small amounts of virus are administered to the bird.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 590%.
This report is a detailed and comprehensive analysis for global Live-type Poultry Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Live-type Poultry Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Live-type Poultry Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Live-type Poultry Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Live-type Poultry Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Live-type Poultry Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Live-type Poultry Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Live-type Poultry Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Newcastle Disease Vaccine
Infectious Bronchitis Vaccine
Fowl Pox Vaccine
Marek’s Disease Vaccine
Fowl Typhoid Vaccine
Live Coccidiosis Vaccine
Other
Market segment by Application
Chicken
Other Poultry
Major players covered
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Live-type Poultry Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live-type Poultry Vaccine, with price, sales quantity, revenue, and global market share of Live-type Poultry Vaccine from 2020 to 2025.
Chapter 3, the Live-type Poultry Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live-type Poultry Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Live-type Poultry Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live-type Poultry Vaccine.
Chapter 14 and 15, to describe Live-type Poultry Vaccine sales channel, distributors, customers, research findings and conclusion.

Buy now